Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Alliance for Clinical Trials in Oncology
Eastern Cooperative Oncology Group
Pfizer
iOnctura
Wake Forest University Health Sciences
Merck Sharp & Dohme LLC
University of California, Davis
Hoffmann-La Roche
University Health Network, Toronto
Children's Oncology Group
Children's Oncology Group
BioInvent International AB
Essen Biotech
Azienda Ospedaliero-Universitaria di Parma
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
M.D. Anderson Cancer Center
NuCana plc
OncoNano Medicine, Inc.
Mayo Clinic
Compass Therapeutics
National Cancer Institute (NCI)
University Health Network, Toronto
Miltenyi Biomedicine GmbH
Cancer Research UK
Cancer Research UK
GlaxoSmithKline
Massive Bio, Inc.
UNC Lineberger Comprehensive Cancer Center
Young Adult Survivors United
Arcus Biosciences, Inc.
Incyte Corporation
Novartis
Region Skane
Shattuck Labs, Inc.
GlaxoSmithKline
Seagen Inc.
National Cancer Institute (NCI)
Checkpoint Therapeutics, Inc.
University Health Network, Toronto
Taproot Health
Vector Vitale LLC
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Cedars-Sinai Medical Center
Sanguine Biosciences
Presage Biosciences
Cancer Support Community, Research and Training Institute, Philadelphia
Celldex Therapeutics